NCT04395040

Brief Summary

A third of cancers are diagnosed in patients over 75 years of age. There are fears of the elderly talking about new symptoms. The doctor may find himself trapped by general symptoms, which can be confused with "normal aging". Some older, younger people have lived in a world where cancer was little talked about, where there was little treatment possible. There is an idea that doctors are not very quick to start curative treatment because they think that the elderly cannot bear it. It is important to differentiate screening and early diagnosis. Delayed treatment causes a decrease in survival and quality of life. Cancer can be discovered suddenly: for example, occlusion with peritonitis in case of a stenosing colonic tumor, leading to urgent management. The elderly are often excluded from clinical studies. In addition, the geriatric population is heterogeneous, leading to very diverse and individual care, with prioritization of issues. Oncogeriatrics, which combines two services (oncology and geriatrics), is a specialized discipline, promoting comprehensive care for the elderly patient with cancer. The general practitioner is at the center of care. It detects early signs and starts examinations if necessary. Cancer care can be divided up with the different stages of care with various teams, including organ specialists. The general practitioner is the privileged interlocutor for the patient and their family (medico-psycho-social plan), who knows their history and their experience.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started May 2020

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 8, 2020

Completed
7 days until next milestone

First Submitted

Initial submission to the registry

May 15, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 20, 2020

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2020

Completed
Last Updated

June 21, 2021

Status Verified

June 1, 2021

Enrollment Period

5 months

First QC Date

May 15, 2020

Last Update Submit

June 18, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Identify the obstacles to the early diagnosis of cancer in patients over 75 years old suffering from cancer.

    Explore, during a semi-structured interview with the patient, the brakes and levers: * related to the patient * linked to the doctor: felt on the practices of health professionals, paternalistic, patient-centered approach * linked to the disease: symptoms, acceptance of examinations, acceptance of diagnosis * linked to society

    1 hour

Study Arms (1)

Patients

Elderly patients with digestive cancer or breast cancer.

Other: Semi-structured interview

Interventions

Semi-structured interview

Patients

Eligibility Criteria

Age75 Years+
Sexall
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Elderly patients with digestive or breast cancer.

You may qualify if:

  • Patients over 75 years old (terminal included)
  • Incident diagnosis
  • Has cancer whose diagnosis dates back more than 3 months
  • Digestive cancer, breast cancer
  • Stage of advanced cancer (TNM stage: T\> T2 (terminal included), M1)
  • According to the opinion of the oncogeriatrician on the time of taking charge
  • Follow-up of a geriatrics service, onco-geriatrics orientation
  • Living in the Rhône department
  • Non-opposition of the patient to the study

You may not qualify if:

  • Cancer diagnosis more than 6 months old
  • Patient denies

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Centre Léon Bérard

Lyon, France

Location

Hôpital Lyon Sud

Pierre-Bénite, France

Location

Centre hospitalier Fleyriat

Viriat, 01440, France

Location

MeSH Terms

Conditions

Neoplasms

Study Officials

  • Camille TAZELMATI, MD Student

    Hospices Civils de Lyon

    PRINCIPAL INVESTIGATOR
  • Marie VALERO, MD

    Hospices Civils de Lyon

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2020

First Posted

May 20, 2020

Study Start

May 8, 2020

Primary Completion

October 2, 2020

Study Completion

October 2, 2020

Last Updated

June 21, 2021

Record last verified: 2021-06

Locations